Table 3.
Control | p value | Intervention | p value | |||
---|---|---|---|---|---|---|
Baseline | Post intervention | Baseline | Post intervention | |||
MA, mg/dL, mean(SD) | 181.19 (± 54.87) | 185.19 (± 60.92) | 0.549a | 178.54 (± 62.81) | 197.92 (± 52.89) | 0.007*,a |
MOF, N, median(IQR) | 539.00 (553.1) | 564.80 (511.6) | 0.683b | 608.45 (434.5) | 905.15 (525.4) | 0.000*,b |
rMMT, mm, mean(SD) | 7.87 (± 1.73) | 7.69 (± 1.92) | 0.280a | 8.89 (± 2.16) | 9.07 (± 2.16) | 0.220a |
cMMT, mm, mean(SD) | 10.33 (± 2.46) | 10.42 (± 2.68) | 0.673a | 11.53 (± 2.61) | 12.65 (± 2.76) | 0.003*,a |
rMMEI, mean(SD) | 158.25 (± 17.89) | 156.30 (± 17.62) | 0.373a | 149.09(± 17.20) | 149.28(± 18.02) | 0.940a |
cMMEI, mean(SD) | 135.39 (± 20.93) | 134.59 (± 18.23) | 0.789a | 131.49(± 16.16) | 124.72(± 16.04) | 0.007*,a |
SD standard deviation, IQR interquartile range, MA masticatory ability, MOF maximum occlusal force, rMMT masseter muscle thickness at rest, cMMT masseter muscle thickness during contraction, rMMEI masseter muscle echo intensity at rest, cMMEI masseter muscle echo intensity during contraction.
*p-value < 0.05.
aPaired t test.
bWilcoxon signed-rank test.